rs200509641

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001009944.3(PKD1):​c.8111C>T​(p.Ala2704Val) variant causes a missense change. The variant allele was found at a frequency of 0.000896 in 1,589,016 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A2704T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00066 ( 0 hom., cov: 20)
Exomes 𝑓: 0.00092 ( 10 hom. )

Consequence

PKD1
NM_001009944.3 missense

Scores

1
18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 4.06

Publications

5 publications found
Variant links:
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
PKD1 Gene-Disease associations (from GenCC):
  • autosomal dominant polycystic kidney disease
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • polycystic kidney disease 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • autosomal recessive polycystic kidney disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Caroli disease
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008843273).
BP6
Variant 16-2104548-G-A is Benign according to our data. Variant chr16-2104548-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 440103.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00066 (99/150012) while in subpopulation SAS AF = 0.00319 (15/4708). AF 95% confidence interval is 0.00196. There are 0 homozygotes in GnomAd4. There are 52 alleles in the male GnomAd4 subpopulation. Median coverage is 20. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 10 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PKD1NM_001009944.3 linkc.8111C>T p.Ala2704Val missense_variant Exon 22 of 46 ENST00000262304.9 NP_001009944.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PKD1ENST00000262304.9 linkc.8111C>T p.Ala2704Val missense_variant Exon 22 of 46 1 NM_001009944.3 ENSP00000262304.4

Frequencies

GnomAD3 genomes
AF:
0.000660
AC:
99
AN:
149894
Hom.:
0
Cov.:
20
show subpopulations
Gnomad AFR
AF:
0.000347
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000530
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000202
Gnomad SAS
AF:
0.00318
Gnomad FIN
AF:
0.00171
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.000548
Gnomad OTH
AF:
0.000969
GnomAD2 exomes
AF:
0.00142
AC:
223
AN:
156602
AF XY:
0.00177
show subpopulations
Gnomad AFR exome
AF:
0.000121
Gnomad AMR exome
AF:
0.000274
Gnomad ASJ exome
AF:
0.000355
Gnomad EAS exome
AF:
0.000324
Gnomad FIN exome
AF:
0.000809
Gnomad NFE exome
AF:
0.00105
Gnomad OTH exome
AF:
0.00204
GnomAD4 exome
AF:
0.000920
AC:
1324
AN:
1439004
Hom.:
10
Cov.:
30
AF XY:
0.00113
AC XY:
806
AN XY:
714798
show subpopulations
African (AFR)
AF:
0.000423
AC:
14
AN:
33068
American (AMR)
AF:
0.000442
AC:
19
AN:
43012
Ashkenazi Jewish (ASJ)
AF:
0.000233
AC:
6
AN:
25718
East Asian (EAS)
AF:
0.000408
AC:
16
AN:
39192
South Asian (SAS)
AF:
0.00538
AC:
450
AN:
83660
European-Finnish (FIN)
AF:
0.00166
AC:
82
AN:
49452
Middle Eastern (MID)
AF:
0.00950
AC:
39
AN:
4106
European-Non Finnish (NFE)
AF:
0.000546
AC:
601
AN:
1101336
Other (OTH)
AF:
0.00163
AC:
97
AN:
59460
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
72
144
216
288
360
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000660
AC:
99
AN:
150012
Hom.:
0
Cov.:
20
AF XY:
0.000710
AC XY:
52
AN XY:
73196
show subpopulations
African (AFR)
AF:
0.000346
AC:
14
AN:
40474
American (AMR)
AF:
0.000529
AC:
8
AN:
15116
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3454
East Asian (EAS)
AF:
0.000202
AC:
1
AN:
4948
South Asian (SAS)
AF:
0.00319
AC:
15
AN:
4708
European-Finnish (FIN)
AF:
0.00171
AC:
18
AN:
10504
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.000548
AC:
37
AN:
67520
Other (OTH)
AF:
0.000959
AC:
2
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000849
Hom.:
0
Bravo
AF:
0.000635
ESP6500AA
AF:
0.000242
AC:
1
ESP6500EA
AF:
0.000242
AC:
2
ExAC
AF:
0.000895
AC:
99

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Jun 08, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PKD1: BP4, BS2 -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:1
Dec 02, 2016
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Polycystic kidney disease, adult type Benign:1
Nov 02, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Polycystic kidney disease Benign:1
-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

The PKD1 p.Ala2704Val variant was identified in 1 of 74 proband chromosomes (frequency: 0.01) from individuals or families with ADPKD (Bataille 2011). The variant was also identified in dbSNP (ID: rs200509641), LOVD 3.0 (2X), and the ADPKD Mutation Database (likely neutral). The variant was not identified in ClinVar, COGR, or PKD1-LOVD databases. The variant was identified in control databases in 239 of 180276 chromosomes at a frequency of 0.001 in the following populations: South Asian in 125 of 23404 chromosomes (freq. 0.005), European in 70 of 73288 chromosomes (freq. 0.001), Finnish in 19 of 15662 chromosomes (freq. 0.001), Other in 8 of 4820 chromosomes (freq. 0.002), Latino in 7 of 25668 chromosomes (freq. 0.0003), East Asian in 4 of 13122 chromosomes (freq.0.0003), African in 3 of 15856 chromosomes (freq. 0.0002), Ashkenazi Jewish in 3 of 8466 chromosomes (freq. 0.0003), increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Consortium Feb 27, 2017). In addition we cannot be certain that data from control databases is specific to PKD1 and not from one of the six PKD1 pseudogenes. This variant was also identified in one individual from our laboratory with a co-occurring pathogenic variant in PKD2 (c.1704dupT, p.Val569CysfsX4), increasing the likelihood this variant does not have clinical significance. The p.Ala2704 residue is not conserved in mammals and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and 2 of 5 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) predict a greater than 10% difference in splicing; this is not very predictive of pathogenicity. In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. -

Autosomal dominant polycystic kidney disease Benign:1
Jan 01, 2019
Molecular Genetics of Inherited Kidney Disorders Laboratory, Garvan Institute of Medical Research
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
14
DANN
Benign
0.95
DEOGEN2
Benign
0.23
T;.
Eigen
Benign
-0.92
Eigen_PC
Benign
-0.97
FATHMM_MKL
Benign
0.53
D
LIST_S2
Benign
0.80
T;T
M_CAP
Pathogenic
0.37
D
MetaRNN
Benign
0.0088
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.0
L;L
PhyloP100
4.1
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-1.3
N;N
REVEL
Benign
0.12
Sift
Benign
0.081
T;T
Sift4G
Benign
0.088
T;T
Polyphen
0.60
P;P
Vest4
0.056
MVP
0.49
ClinPred
0.020
T
GERP RS
-0.39
Varity_R
0.027
gMVP
0.15
Mutation Taster
=77/23
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200509641; hg19: chr16-2154549; COSMIC: COSV51913852; COSMIC: COSV51913852; API